Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

pudepharma

Explore full profile

GMP-certified manufacturer of pharmaceutical raw materials and injections

Datong, ChinaFounded 1995Semiconductors
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for pudepharma and the history behind them.

About pudepharma

Shanxi Powerdone Pharmaceutics Co., Ltd. is a GMP-certified pharmaceutical company located in Datong, China, specializing in the manufacturing of both raw medical materials and finished drug products. Founded in September 1995 as a joint venture between Datong Puhua Leading Industry & Trade Co., Ltd. and the US New York Business Trade Corporation, the company has grown into a significant player in the Chinese pharmaceutical market. In 2015, it became a holding subsidiary of Harbin Yuheng Pharmaceutical.

The company operates multiple production lines, including facilities for freeze-dried powders, injections, raw materials, and traditional Chinese medicine. Its product portfolio is diverse, featuring finished injection medicines like anti-tumor drugs, non-penicillin injections, and cephalosporins, as well as sterile and non-sterile raw materials. Specific products include Ramosetron Hydrochloride, Ranitidine Hydrochloride, and Naloxone Hydrochloride for injection. The company's business model encompasses manufacturing and exporting, with a portion of its revenue generated from international sales. It also offers OEM and buyer label services. The company was acquired by Harbin Yuheng Pharmaceutical on April 4, 2015.

Key milestones in the company's history include receiving its first GMP certificate in 2001, initiating the construction of an anti-tumor injection project in 2003, and completing a shareholding system transformation in 2010. The company relocated to the First Pharmaceutical Park in 2013.

Source: Dealroom company data

At a glance

Founded
1995
Headquarters
Datong, China
Sector
Semiconductors

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • JD Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Datong HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about pudepharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See pudepharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.